|
Sign In to gain access to subscriptions and/or personal tools.
|
Diagnostic definitions — metabolic syndrome
Caroline Day
Diabetes Group, Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK, cday{at}mededuk.com
References
- Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin N Am 2004;33:283-303.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Himsworth HP Diabetes Mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1936; Jan 18th: 5864-8.
- Hales CN, Randle PJ Immunoassay of insulin with insulin-antibody precipitate. Biochem J 1963;88:137-46.[Web of Science][Medline]
[Order article via Infotrieve]
- Marks V. An improved glucose-oxidase method for determining blood, C.S.F. and urine glucose levels. Clin Chim Acta 1959;4:395-400.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Reaven GM Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.[Abstract]
- Alberti KG, Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation, Geneva; 1999. Report No. 99.2. (http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf)
- Balkau B., Charles MA Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-3.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Grundy SM, Brewer B. Jr, Cleeman JI et al. Definition of metabolic syndrome. Circulation 2004;109:433-8. (2004 guidelines at www.nhlbi.nih.gov/guidelines/cholesterol/atglance.pdf )[Free Full Text]
- Einhorn D., Reaven GM, Cobin RH et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-52.[Medline]
[Order article via Infotrieve]
- The IDF consensus worldwide definition of the metabolic syndrome, 2005 http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf
- Ford ES, Wayne HG, Mokdad AH Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004;27:2444-9.[Abstract/Free Full Text]
- The DECODE Study Group. Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. Br J Diabetes Vasc Dis 2005;5:161-8.[Abstract/Free Full Text]
- Eckel RH, Scott MG, Zimmet PZ The metabolic syndrome. Lancet 2005; 365;1415-28.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sattar N., Tan CE, Han TS et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord 1998;22:432-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Goodpaster BH, Krishnaswami S., Harris TB et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch intern Med 2005;165:777-83.[Abstract/Free Full Text]
- Paradisi G., Smith L., Burnter C. et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999;22:1310-17.[Abstract]
- Wajchenberg BL Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Revs 2000;21:697-738.[Abstract/Free Full Text]
- St-Onge M-P., Janssen I., Heymsfield SB Metabolic syndrome in North Americans. New definition of the metabolically obese, normal weight individual. Diabetes Care 2004;27:2222-8.[Abstract/Free Full Text]
- Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Kotani K., Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 1995;3:187S-194S.[Medline]
[Order article via Infotrieve]
- Bailey CJ, Day C. New pharmacological approaches to obesity. Obesity in Practice 2005;1:2-5.
- Padwal R., Li SK, Lau DC Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes Relat Metab Disord 2003;27:1437-46.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Day C., Bailey CJ Sibutramine update. Br J Diabetes Vasc Dis 2002;2: 392-7.[Abstract/Free Full Text]
- Wirth A. Reduction of body weight and co-morbidities by orlistat: The XXL-Primary Health Care Trial. Diabetes Obesity Metabol 2004;7:21-7.
- Finer N., Pagotto U. The endocannabinoid system: a new therapeutic target for cardiovascular risk factor management. Br J Diabetes Vasc Dis 2005;5:121-4.[Abstract/Free Full Text]
- Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O., Rossner S.; RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365:1389-97.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Stratus - US study results announced at American College of Cardiology Annual Meeting, New Orleans, March 9 2004. Press release, www.sanofi-synthelabo.com
The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 3,
115-118 (2005)
DOI: 10.1177/14746514050050030101
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
I. Broom
Review: Thinking around abdominal obesity and cardiovascular risk
The British Journal of Diabetes & Vascular Disease,
March 1, 2006;
6(2):
58 - 61.
[Abstract]
[PDF]
|
|
|
|
|
